Methotrexate
Methotrexate (MTX) is a folate antagonist and one of the most widely used agents in both oncology and immunology.
Methotrexate (MTX) is a folate antagonist and one of the most widely used agents in both oncology and immunology. It acts by competitively inhibiting dihydrofolate reductase (DHFR), the enzyme responsible for reducing dihydrofolate to tetrahydrofolate, thereby disrupting DNA synthesis, repair, and cellular replication. This dual utility — as a cytotoxic chemotherapeutic and as an immunosuppressive disease-modifying antirheumatic drug (DMARD) — makes it a cornerstone of treatment across an exceptionally broad range of conditions, including malignancies such as osteosarcoma, acute lymphoblastic leukemia (ALL), and diffuse large B-cell lymphoma (DLBCL), as well as inflammatory and autoimmune disorders including rheumatoid arthritis, psoriasis, bullous pemphigoid, scleritis, and retroperitoneal fibrosis.
At lower doses, MTX modulates immune function by suppressing lymphocyte proliferation and downregulating pro-inflammatory cytokines, making it a preferred anchor agent in rheumatological and dermatological practice. At high doses, it exerts direct antiproliferative cytotoxicity, and its pharmacokinetics in these settings require careful monitoring given the potential for significant organ toxicity, including hepatotoxicity, nephrotoxicity, and mucositis. Because of this breadth of application and its established efficacy benchmark, MTX remains a critical comparator in experimental therapeutics and a frequent component of combination regimens evaluated in current research.
Where the papers sit
22 papers from the last 6 months study methotrexate directly · updated from PubMed 16 Nov 2026
Study type 1 clinical trial · 8 observational · 3 human data · 8 preclinical · 2 unclassified
Themes one subject · 1 paradigm shift · 1 new direction
Those 22 are all about one subject.
-
Methotrexate Treatment and Toxicity
Methotrexate research here links treatment optimization with pharmacokinetics, delivery, efficacy, and toxicity across cancer, psoriasis, ectopic pregnancy, and inflammatory disease. Microneedle, nanogel, nanoliposome, and phage platforms seek targeted or transdermal delivery, while combination strategies add TNF-α siRNA or protective agents. Clinical studies address ultrasound predictors, high-dose exposure, dose intensity, mucositis prevention, and rare fatal toxicity in renal failure. The work remains broad rather than converging on a single mechanism, with safety and therapeutic precision as recurring goals.
Increasing methotrexate exposure does not reliably improve cancer outcomes
In ultra-high-risk large B-cell lymphoma, high-dose methotrexate was assumed to prevent central nervous system relapse, but an international multicenter analysis found no significant reduction in relapse compared with no prophylaxis; in high-grade osteosarcoma, greater methotrexate-containing MAP dose intensity likewise was not consistently associated with improved progression-free or overall survival. Together, these findings challenge dose escalation as a generally reliable way to improve methotrexate-based cancer treatment and shift attention toward selecting patients and strategies on the basis of demonstrated benefit rather than intensity alone 42274647Jun 42502976Jul.
Methotrexate is used as an electrochemical analyte for medication-safety monitoring
In a poly(alizarin red)/gold-nanoflower/molybdenum-disulfide electrochemical sensor, methotrexate was not primarily treated as an anticancer or immunosuppressive agent but as the molecule to be detected and quantified through its oxidation signal. This assigns methotrexate a distinct analytical role: enabling sensitive measurement of drug exposure to support safer clinical use 42627469Aug.
Papers
The 22 papers from the last 6 months that study methotrexate directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Methotrexate Treatment and Toxicity (22)
- Endometrial ultrasound features associated with methotrexate success in tubal ectopic pregnancy: a prospective case series. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 14 Nov 2026 PMID 43033463
- Capturing Transient Intermediate Assembly States Enables Hierarchical Core-Shell Microassemblies with Spatiotemporal Release for Psoriasis Therapy. ACS nano · 27 Oct 2026 PMID 42937559
- Population pharmacokinetic model of high-dose methotrexate in Malaysian adults with hematological malignancies. European journal of clinical pharmacology · 6 Oct 2026 PMID 42836986
- Methotrexate's effect on cells and adalimumab immunogenicity in axial spondyloarthritis: A mathematical study. PLoS computational biology · 21 Sept 2026 PMID 42766629
- Spatiotemporal bilayer microneedle patch potentiates methotrexate therapy in psoriasis by breaking the hypoxia-ROS vicious cycle. Journal of controlled release : official journal of the Controlled Release Society · 17 Sept 2026 PMID 42753824
- Biohybrid M13 phage backpacks for active blood-brain barrier traversal and precision central nervous system leukemia treatment. Biomarker research · 17 Sept 2026 PMID 42750063
- H3K27M drives OPC stemness and intrathecal therapeutic vulnerability in brainstem glioma organoids. Cell stem cell · 16 Sept 2026 PMID 42748922
- Therapeutic effects of Rosmarinus officinalis against methotrexate-induced submandibular salivary gland injury in male albino rats. Journal of molecular histology · 15 Sept 2026 PMID 42742856
- Chitosan-PLGA biopolymeric nanogel as a platform for enhanced methotrexate delivery and redox-modulated anti-inflammatory activity. Bioorganic chemistry · 27 Aug 2026 PMID 42660045
- Enhanced mitigation of diabetic myocardial injury in rats via modulating the adiponectin/IRS-1/PI3K/p-AKT/FOXO-1 signaling by combining methotrexate and insulin. Molecular biology reports · 22 Aug 2026 PMID 42631883
- Fatal intoxication caused by conventional-dose methotrexate in an elderly patient with end-stage renal disease: A cautionary case report. Medicine · 22 Aug 2026 PMID 42629702
- A highly sensitive electrochemical sensor based on poly(alizarin red)/gold nanoflowers/molybdenum disulfide composite for the detection of methotrexate. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 21 Aug 2026 PMID 42627469
- Transdermal drug delivery platform for psoriasis: co-delivery of methotrexate and TNF-α siRNA via hydrogel microneedles. Nanoscale horizons · 18 Aug 2026 PMID 42610519
- Effectiveness of oral cryotherapy in preventing methotrexate-induced oral mucositis in pediatric patients with acute lymphoblastic leukemia: a randomized controlled trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 14 Aug 2026 PMID 42599331
- Protective effects of icariin-loaded nanoliposomes against methotrexate-induced testicular toxicity via modulation of NRF2/NF-κB and ferroptosis signaling. Reproductive toxicology (Elmsford, N.Y.) · 13 Aug 2026 PMID 42595098
- Dose intensity and clinical outcomes across age groups in high-grade osteosarcoma treated with methotrexate, adriamycin, and cisplatin therapy. Japanese journal of clinical oncology · 26 Jul 2026 PMID 42502976
- Methotrexate potentiates oxidative stress-mediated transdifferentiation and metabolic reprogramming of neutrophils. Journal of bioenergetics and biomembranes · 21 Jul 2026 PMID 42479252
- Glucocorticoid monotherapy versus combination with methotrexate or tocilizumab in giant cell arteritis: efficacy and safety at 78 weeks in a retrospective cohort study. Medicina clinica · 28 Jun 2026 PMID 42365805
- Impact of oral mucositis treated by photobiomodulation protocol on the quality of life of pediatric oncology patients with acute lymphoblastic leukemia. Lasers in medical science · 12 Jun 2026 PMID 42283739
- High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 11 Jun 2026 PMID 42274647
- Formulation and in-vitro characterization of okra mucilage-based controlled release hydrogels. Pakistan journal of pharmaceutical sciences · 9 Jun 2026 PMID 42262204
- Increased Mortality in Patients with Bullous Pemphigoid: A Nationwide Population-based Cohort Study of 5,738 Patients in Sweden. Acta dermato-venereologica · 28 May 2026 PMID 42206441
By study type
Clinical trials (1)
- Effectiveness of oral cryotherapy in preventing methotrexate-induced oral mucositis in pediatric patients with acute lymphoblastic leukemia: a randomized controlled trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 14 Aug 2026 PMID 42599331
Observational studies and case reports (8)
- Endometrial ultrasound features associated with methotrexate success in tubal ectopic pregnancy: a prospective case series. Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 14 Nov 2026 PMID 43033463
- Population pharmacokinetic model of high-dose methotrexate in Malaysian adults with hematological malignancies. European journal of clinical pharmacology · 6 Oct 2026 PMID 42836986
- Fatal intoxication caused by conventional-dose methotrexate in an elderly patient with end-stage renal disease: A cautionary case report. Medicine · 22 Aug 2026 PMID 42629702
- Dose intensity and clinical outcomes across age groups in high-grade osteosarcoma treated with methotrexate, adriamycin, and cisplatin therapy. Japanese journal of clinical oncology · 26 Jul 2026 PMID 42502976
- Glucocorticoid monotherapy versus combination with methotrexate or tocilizumab in giant cell arteritis: efficacy and safety at 78 weeks in a retrospective cohort study. Medicina clinica · 28 Jun 2026 PMID 42365805
- Impact of oral mucositis treated by photobiomodulation protocol on the quality of life of pediatric oncology patients with acute lymphoblastic leukemia. Lasers in medical science · 12 Jun 2026 PMID 42283739
- High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 11 Jun 2026 PMID 42274647
- Increased Mortality in Patients with Bullous Pemphigoid: A Nationwide Population-based Cohort Study of 5,738 Patients in Sweden. Acta dermato-venereologica · 28 May 2026 PMID 42206441
Human data, design not indexed (3)
- Capturing Transient Intermediate Assembly States Enables Hierarchical Core-Shell Microassemblies with Spatiotemporal Release for Psoriasis Therapy. ACS nano · 27 Oct 2026 PMID 42937559
- Methotrexate's effect on cells and adalimumab immunogenicity in axial spondyloarthritis: A mathematical study. PLoS computational biology · 21 Sept 2026 PMID 42766629
- Methotrexate potentiates oxidative stress-mediated transdifferentiation and metabolic reprogramming of neutrophils. Journal of bioenergetics and biomembranes · 21 Jul 2026 PMID 42479252
Preclinical: animal, cell and lab studies (8)
- Spatiotemporal bilayer microneedle patch potentiates methotrexate therapy in psoriasis by breaking the hypoxia-ROS vicious cycle. Journal of controlled release : official journal of the Controlled Release Society · 17 Sept 2026 PMID 42753824
- Therapeutic effects of Rosmarinus officinalis against methotrexate-induced submandibular salivary gland injury in male albino rats. Journal of molecular histology · 15 Sept 2026 PMID 42742856
- Chitosan-PLGA biopolymeric nanogel as a platform for enhanced methotrexate delivery and redox-modulated anti-inflammatory activity. Bioorganic chemistry · 27 Aug 2026 PMID 42660045
- Enhanced mitigation of diabetic myocardial injury in rats via modulating the adiponectin/IRS-1/PI3K/p-AKT/FOXO-1 signaling by combining methotrexate and insulin. Molecular biology reports · 22 Aug 2026 PMID 42631883
- A highly sensitive electrochemical sensor based on poly(alizarin red)/gold nanoflowers/molybdenum disulfide composite for the detection of methotrexate. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 21 Aug 2026 PMID 42627469
- Transdermal drug delivery platform for psoriasis: co-delivery of methotrexate and TNF-α siRNA via hydrogel microneedles. Nanoscale horizons · 18 Aug 2026 PMID 42610519
- Protective effects of icariin-loaded nanoliposomes against methotrexate-induced testicular toxicity via modulation of NRF2/NF-κB and ferroptosis signaling. Reproductive toxicology (Elmsford, N.Y.) · 13 Aug 2026 PMID 42595098
- Formulation and in-vitro characterization of okra mucilage-based controlled release hydrogels. Pakistan journal of pharmaceutical sciences · 9 Jun 2026 PMID 42262204
Unclassified: not yet indexed with MeSH (2)
- Biohybrid M13 phage backpacks for active blood-brain barrier traversal and precision central nervous system leukemia treatment. Biomarker research · 17 Sept 2026 PMID 42750063
- H3K27M drives OPC stemness and intrathecal therapeutic vulnerability in brainstem glioma organoids. Cell stem cell · 16 Sept 2026 PMID 42748922
Written from 22 PubMed abstracts, each one listed by PMID above. Published: 2026-06-16. Last written: 2026-09-23 by GPT. Drafted by language models from published abstracts; not medical advice.